Boston Partners’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-144,235
Closed -$10.6M 822
2023
Q4
$10.6M Sell
144,235
-6,270
-4% -$424K 0.01% 383
2023
Q3
$10.8M Sell
150,505
-4,384
-3% -$350K 0.01% 357
2023
Q2
$12.8M Sell
154,889
-6,366
-4% -$557K 0.02% 349
2023
Q1
$14.4M Buy
161,255
+13,153
+9% +$1.14M 0.02% 328
2022
Q4
$12.7M Sell
148,102
-4,346
-3% -$368K 0.02% 332
2022
Q3
$11.4M Sell
152,448
-141,386
-48% -$12.6M 0.02% 342
2022
Q2
$28.8M Buy
+293,834
New +$30M 0.04% 276

Other funds holding QDEL

Boston Partners's QDEL Position: Q1 2024 in Review

Boston Partners sold out of QuidelOrtho (QDEL) in Q1 2024, closing a stake of 144,235 shares — an estimated $10.6M sold.

Boston Partners first reported a position in QDEL in Q2 2022 and held it in 7 quarters. The position peaked at $28.8M in Q2 2022. 271 funds tracked by Wall St. Rank hold QDEL as of Q1 2024.

  • Boston Partners reported no remaining QuidelOrtho position as of Q1 2024 after selling out during the quarter.
  • Boston Partners sold 144,235 QuidelOrtho shares in Q1 2024, an estimated $10.6M.
  • Boston Partners first reported a position in QuidelOrtho in Q2 2022 and held it in 7 quarters.
  • Boston Partners's QuidelOrtho position peaked at $28.8M in Q2 2022.
  • 271 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2024.

Based on Boston Partners's 13F filing for Q1 2024, filed 13 May 2024.